Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Treatt plc (TET.L)
GBp305.00
+0.50 (+0.16%)
GB LSE Basic Materials Chemicals - Specialty
Address
Skyliner Way IP32 7FR
Bury St Edmunds, SFK, GB
Bury St Edmunds, SFK, GB
CEO
Manprit Singh Randhawa
Website
treatt.com
IPO
1989-06-21
ISIN GB00BKS7YK08
Description
Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts for beverage, flavor, and fragrance markets in the United Kingdom, Germany, Ireland, Europe, the United States, China, and internationally. The company offers beverages, such as carbonates; juices; energy waters; RTD coffee and tea; kombucha; healthy sodas; sports; beers; spirits; flavored alcoholic beverages; and low and no alcohols. It also provides zesty; floral; chemicals; flavor ingredients, such as citrus, coffee, tea, health and wellness, and fruits and vegetables extracts; and aroma, and herb, spice, and floral ingredients. The company was founded in 1886 and is based in Bury Saint Edmunds, the United Kingdom.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
GBp305.00
+0.50 (+0.16%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
408.3K
Beta
0.91
Float Shares
40.92M
Free Float %
69.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.33% | +0.50% | +42.18% | +42.18% | +35.14% | +47.06% | +14.29% | -57.57% | -73.57% | +67.60% | +1,307.79% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
305.00
DCF (Unlevered)
340.79
+11.7%
DCF (Levered)
164.29
-46.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
33% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.69
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-13.5% Q1'26: -17.0% (vs Q1'24)
-
EPS growth Chemicals - Specialty: +13.2%-63.7% Q1'26: -71.5% (vs Q1'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.9% Q1'26: +2.4% (vs Q1'24)
-
EBIT margin Chemicals - Specialty: +8.8%+5.8% Q1'26: +4.7% (vs Q1'24)
-
ROIC Chemicals - Specialty: +5.6%+3.9% Q1'26: +5.8% (vs Q1'24)
-
Share dilution Chemicals - Specialty: +0.1%-1.3% ★ Q1'26: -2.6% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.64× Q1'26: 0.29× (vs Q1'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2011 actual |
Sep 2012 actual |
Sep 2013 actual |
Sep 2014 actual |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 4 Rev. Ana. 4 EPS Ana. |
Sep 2027 4 Rev. Ana. 4 EPS Ana. |
Sep 2028 3 Rev. Ana. 1 EPS Ana. |
Sep 2029 1 Rev. Ana. 1 EPS Ana. |
Sep 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
74.52M
est: 72.67M (+2.5%)
|
74.01M
est: 73.08M (+1.3%)
|
74.10M
est: 76.20M (-2.8%)
|
79.19M
est: 79.83M (-0.8%)
|
85.93M
est: 86.13M (-0.2%)
|
88.04M
est: 88.04M (0.0%)
|
109.63M
est: 108.86M (+0.7%)
|
112.16M
est: 110.47M (+1.5%)
|
112.72M
est: 112.76M (0.0%)
|
109.02M
est: 109.25M (-0.2%)
|
124.33M
est: 124.00M (+0.3%)
|
140.19M
est: 140.00M (+0.1%)
|
147.40M
est: 143.55M (+2.7%)
|
153.07M
est: 155.20M (-1.4%)
|
132.47M
est: 130.51M (+1.5%)
|
136.18M
132.00M – 138.23M
+4.3% YoY
|
142.09M
138.68M – 145.42M
+4.3% YoY
|
148.54M
147.72M – 149.35M
+4.5% YoY
|
155.00M
150.77M – 158.00M
+4.4% YoY
|
160.00M
155.64M – 163.10M
+3.2% YoY
|
| EBITDA |
8.12M
est: 10.58M (-23.2%)
|
6.40M
est: 10.63M (-39.8%)
|
7.27M
est: 5.38M (+35.1%)
|
7.55M
est: 6.18M (+22.2%)
|
9.84M
est: 6.89M (+42.9%)
|
10.37M
est: 8.86M (+17.0%)
|
13.86M
est: 11.54M (+20.2%)
|
13.56M
est: 13.93M (-2.6%)
|
14.01M
est: 15.55M (-9.9%)
|
15.70M
est: 13.63M (+15.2%)
|
21.52M
est: 14.45M (+48.9%)
|
19.05M
est: 15.25M (+24.9%)
|
19.31M
est: 20.02M (-3.6%)
|
24.22M
est: 21.64M (+11.9%)
|
13.16M
est: 18.21M (-27.7%)
|
19.00M
18.41M – 19.28M
+4.3% YoY
|
19.82M
19.35M – 20.29M
+4.3% YoY
|
20.72M
20.61M – 20.83M
+4.5% YoY
|
21.62M
21.03M – 22.04M
+4.4% YoY
|
22.32M
21.71M – 22.75M
+3.2% YoY
|
| EBIT |
6.95M
est: 8.93M (-22.2%)
|
5.09M
est: 8.98M (-43.3%)
|
5.81M
est: 5.21M (+11.5%)
|
6.07M
est: 6.08M (-0.2%)
|
8.30M
est: 6.79M (+22.3%)
|
8.75M
est: 8.71M (+0.5%)
|
12.38M
est: 11.12M (+11.3%)
|
11.98M
est: 12.73M (-6.0%)
|
12.64M
est: 13.11M (-3.6%)
|
13.85M
est: 13.14M (+5.5%)
|
19.72M
est: 13.93M (+41.6%)
|
16.36M
est: 14.70M (+11.3%)
|
14.63M
est: 16.00M (-8.6%)
|
19.15M
est: 17.30M (+10.7%)
|
7.65M
est: 14.55M (-47.4%)
|
15.18M
14.72M – 15.41M
+4.3% YoY
|
15.84M
15.46M – 16.21M
+4.3% YoY
|
16.56M
16.47M – 16.65M
+4.5% YoY
|
17.28M
16.81M – 17.62M
+4.4% YoY
|
17.84M
17.35M – 18.18M
+3.2% YoY
|
| Net Income |
4.35M
est: 5.35M (-18.8%)
|
3.07M
est: 4.06M (-24.3%)
|
3.48M
est: 3.23M (+7.6%)
|
3.95M
est: 3.67M (+7.7%)
|
5.99M
est: 4.27M (+40.3%)
|
6.15M
est: 6.13M (+0.4%)
|
9.55M
est: 7.60M (+25.6%)
|
12.23M
est: 9.69M (+26.2%)
|
8.79M
est: 12.48M (-29.6%)
|
9.77M
est: 9.06M (+7.8%)
|
15.15M
est: 9.60M (+57.7%)
|
13.32M
est: 10.58M (+25.8%)
|
10.94M
est: 11.31M (-3.3%)
|
14.40M
est: 14.35M (+0.4%)
|
5.06M
est: 7.40M (-31.5%)
|
7.86M
7.35M – 8.65M
+6.3% YoY
|
8.88M
8.17M – 9.59M
+12.9% YoY
|
9.54M
9.25M – 9.83M
+7.4% YoY
|
10.90M
10.52M – 11.18M
+14.3% YoY
|
11.51M
11.10M – 11.80M
+5.6% YoY
|
| SGA |
10.69M
est: 11.97M (-10.7%)
|
11.32M
est: 11.88M (-4.7%)
|
10.65M
est: 11.78M (-9.6%)
|
10.34M
est: 11.11M (-6.9%)
|
10.29M
est: 11.28M (-8.8%)
|
10.85M
est: 10.52M (+3.1%)
|
13.00M
est: 13.42M (-3.1%)
|
13.81M
est: 12.91M (+7.0%)
|
15.16M
est: 14.10M (+7.5%)
|
16.78M
est: 15.54M (+8.0%)
|
20.88M
est: 16.48M (+26.7%)
|
23.31M
est: 17.39M (+34.1%)
|
26.50M
est: 24.39M (+8.7%)
|
24.62M
est: 26.36M (-6.6%)
|
23.14M
est: 22.17M (+4.3%)
|
23.14M
22.43M – 23.49M
+4.3% YoY
|
24.14M
23.56M – 24.71M
+4.3% YoY
|
25.24M
25.10M – 25.37M
+4.5% YoY
|
26.33M
25.62M – 26.84M
+4.4% YoY
|
27.18M
26.44M – 27.71M
+3.2% YoY
|
| EPS |
0.09
est: 0.09 (-4.0%)
|
0.06
est: 0.07 (-10.7%)
|
0.07
est: 0.09 (-21.9%)
|
0.08
est: 0.10 (-24.6%)
|
0.12
est: 0.11 (+8.0%)
|
0.12
est: 0.13 (-7.0%)
|
0.18
est: 0.19 (-3.9%)
|
0.22
est: 0.17 (+28.7%)
|
0.15
est: 0.18 (-16.7%)
|
0.17
est: 0.19 (-10.2%)
|
0.25
est: 0.27 (-5.8%)
|
0.22
est: 0.20 (+12.6%)
|
0.18
est: 0.19 (-3.1%)
|
0.24
est: 0.24 (+0.8%)
|
0.08
est: 0.12 (-31.7%)
|
0.13
0.12 – 0.14
+9.5% YoY
|
0.15
0.13 – 0.16
+9.2% YoY
|
0.16
0.15 – 0.16
+7.9% YoY
|
0.18
0.17 – 0.18
+13.7% YoY
|
0.19
0.18 – 0.19
+5.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
9.11M
OE per share TTM
0.15
Owner's Yield
5.12%
Maintenance CapEx ratio
455.45%
Maint CapEx / Avg PPE
46.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
1
Total invested
189.8K
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
1
+1 vs prev Q
New positions
1
Closed positions
0
Increased
1
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ALBERT D MASON INC | 73.0K +73.0K (+100.0%) | 189.8K +189.8K (+100.0%) | 0.12% +0.121 pp | 0.12% +0.123 pp | GBp196.60 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR FTSE UK All Share UCITS ETF (Dist) FTAD.L | 0.00% | 45.6K | 0.20% |
| 2 | State Street SPDR FTSE UK All Share UCITS ETF (Acc) FTAL.L | 0.00% | 45.6K | 0.20% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
21.7K
Shares Outstanding
59.04M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Angie Williams | Head of Acceleration | — | — |
| Babette Norman | Vice President of Operations | — | male |
| Emma Bowles | Director of Category & Marketing | — | female |
| Gavin Patrick | Global Vice President of Sales | — | male |
| Helen Pizzie | Global Technology Officer | — | — |
| Jaynie Vincent | Interim People Director | — | female |
| Kelly Gordon | Group Finance Director & Investor Relations Lead | — | — |
| Manprit Singh Randhawa | Interim Group MD, Interim CFO & Director | — | male |
| Nicholas Hartigan | General Counsel & Company Secretary | — | male |
| Paul Kollesoff | Director of Strategy & Corporate Development | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TET.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
